Table of Contents Author Guidelines Submit a Manuscript
Journal of Obesity
Volume 2010, Article ID 651903, 5 pages
http://dx.doi.org/10.1155/2010/651903
Research Article

Role of BMI in the Association of the TCF7L2 rs7903146 Variant with Coronary Heart Disease: The Atherosclerosis Risk in Communities (ARIC) Study

1Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC 27514, USA
2Division of Epidemiology, Department of Health Services Research, Mayo Clinic, Rochester, MN 55905, USA
3Human Genetics Center and Division of Epidemiology, University of Texas, Houston, TX 77225, USA
4Department of Medicine, University of Washington, Seattle, WA 98195, USA
5Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN 55454, USA
6Department of Epidemiology, Johns Hopkins University, Baltimore, MD 21205, USA

Received 29 June 2009; Revised 10 December 2009; Accepted 14 January 2010

Academic Editor: Gianluca Iacobellis

Copyright © 2010 Anna M. Kucharska-Newton et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Cauchi and P. Froguel, “TCF7L2 genetic defect and type 2 diabetes,” Current Diabetes Reports, vol. 8, no. 2, pp. 149–155, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Yan, K. E. North, C. M. Ballantyne et al., “Transcription factor 7-like 2 (TCF7L2) polymorphism and context-specific risk of type 2 diabetes in African American and Caucasian adults: the atherosclerosis risk in communities (ARIC) study,” Diabetes, vol. 58, pp. 285–289, 2008. View at Google Scholar
  3. S. Cauchi, H. Choquet, R. Gutierrez-Aguilar et al., “Effects of TCF7L2 polymorphisms on obesity in European populations,” Obesity, vol. 16, no. 2, pp. 476–482, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Cauchi, K. T. Nead, H. Choquet et al., “The genetic susceptibility to type 2 diabetes may be modulated by obesity status: implications for association studies,” BMC Medical Genetics, vol. 9, article 45, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Helgason, S. Palsson, G. Thorleifsson et al., “Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution,” Nature Genetics, vol. 39, no. 2, pp. 218–225, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Stamler, O. Vaccaro, J. D. Neaton, and D. Wentworth, “Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial,” Diabetes Care, vol. 16, no. 2, pp. 434–444, 1993. View at Google Scholar · View at Scopus
  7. The ARIC Investigators, “The Atherosclerosis Risk in Community (ARIC) study. Design and objectives,” American Journal of Epidemiology, vol. 129, pp. 687–702, 1989. View at Google Scholar
  8. Atherosclerosis Risk in Communities Study Manual E.
  9. “Obesity: preventing and managing the global epidemic,” Report of a WHO Consultation on Obesity, World Health Organization, Geneva, Switzerland, 1998, Consulation on Obesity.
  10. S. J. Bielinski, J. S. Pankow, A. R. Folsom, K. E. North, and E. Boerwinkle, “TCF7L2 single nucleotide polymorphisms, cardiovascular disease and all-cause mortality: the Atherosclerosis Risk in Communities (ARIC) study,” Diabetologia, vol. 51, no. 6, pp. 968–970, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Yi, J. Sun, G. E. Lim, I. G. Fantus, P. L. Brubaker, and T. Jin, “Cross talk between the insulin and Wnt signaling pathways: evidence from intestinal endocrine L cells,” Endocrinology, vol. 149, no. 5, pp. 2341–2351, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. S. A. Schafer, O. Tschritter, F. Machicao et al., “Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms,” Diabetologia, vol. 50, no. 12, pp. 2443–2450, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. M. K. Loder, G. D. S. Xavier, A. McDonald, and G. A. Rutter, “TCF7L2 controls insulin gene expression and insulin secretion in mature pancreatic Î2-cells,” Biochemical Society Transactions, vol. 36, no. 3, pp. 357–359, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. S. E. Ross, N. Hemati, K. A. Longo et al., “Inhibition of adipogenesis by Wnt signaling,” Science, vol. 289, no. 5481, pp. 950–953, 2000. View at Publisher · View at Google Scholar · View at Scopus